BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 16809290)

  • 21. Genetic evidence of transmission of human T cell lymphotropic virus type 1 between spouses.
    Iga M; Okayama A; Stuver S; Matsuoka M; Mueller N; Aoki M; Mitsuya H; Tachibana N; Tsubouchi H
    J Infect Dis; 2002 Mar; 185(5):691-5. PubMed ID: 11865428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of human T-cell leukemia virus type 1 replication by antisense env oligodeoxynucleotide.
    Maeda N; Kawamura T; Hoshino H; Yamada N; Blackard J; Kushida S; Miyano-Kurosaki N; Yamamoto N; Makino K; Yokota T; Uchida K; Miwa M
    Biochem Biophys Res Commun; 1998 Feb; 243(1):109-12. PubMed ID: 9473488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human T-lymphotropic virus type II and neurological disease.
    Araujo A; Hall WW
    Ann Neurol; 2004 Jul; 56(1):10-9. PubMed ID: 15236397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms at GLUT1 gene are not associated with the development of TSP/HAM in Brazilian HTLV-1 infected individuals and the discovery of a new polymorphism at GLUT1 gene.
    Costa GC; Azevedo R; Gadelha SR; Kashima SH; Muricy G; Olavarria VN; Covas DT; Takayanagui OM; Galvão-Castro B; Alcantara LC
    J Med Virol; 2009 Mar; 81(3):552-7. PubMed ID: 19152396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular localization and cellular factors interaction of HTLV-1 and HTLV-2 Tax proteins: similarities and functional differences.
    Bertazzoni U; Turci M; Avesani F; Di Gennaro G; Bidoia C; Romanelli MG
    Viruses; 2011 May; 3(5):541-560. PubMed ID: 21994745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleo-cytoplasmic redistribution of the HTLV-I Rex protein: alterations by coexpression of the HTLV-I p21x protein.
    Kubota S; Hatanaka M; Pomerantz RJ
    Virology; 1996 Jun; 220(2):502-7. PubMed ID: 8661402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human T-cell lymphotropic virus types I and II (HTLV-I and -II) infection among seroindeterminate cases in Argentina.
    Berini CA; Eirin ME; Pando MA; Biglione MM
    J Med Virol; 2007 Jan; 79(1):69-73. PubMed ID: 17133550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virology. Forced entry--or does HTLV-I have the key?
    Derse D; Heidecker G
    Science; 2003 Mar; 299(5613):1670-1. PubMed ID: 12637723
    [No Abstract]   [Full Text] [Related]  

  • 29. GLUT1 is not the primary binding receptor but is associated with cell-to-cell transmission of human T-cell leukemia virus type 1.
    Takenouchi N; Jones KS; Lisinski I; Fugo K; Yao K; Cushman SW; Ruscetti FW; Jacobson S
    J Virol; 2007 Feb; 81(3):1506-10. PubMed ID: 17108050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arsenic trioxide induces down-regulation of gp46 via protein oxidation: proteomics analysis of oxidative modified proteins in As2O3-treated HTLV-1-infected cells.
    Nabeshi H; Yoshikawa T; Kamada H; Shibata H; Sugita T; Abe Y; Nagano K; Nomura T; Minowa K; Tsunoda S; Tsutsumi Y
    Pharmazie; 2010 Sep; 65(9):702-7. PubMed ID: 21038850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional localization of the putative cell surface receptor for HTLV-I to human chromosome 17q23.2-17q25.3.
    Gavalchin J; Fan N; Waterbury PG; Corbett E; Faldasz BD; Peshick SM; Poiesz BJ; Papsidero L; Lane MJ
    Virology; 1995 Sep; 212(1):196-203. PubMed ID: 7676629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanisms affecting HTLV type 1-dependent fusion at the cell membrane: implications for inhibiting viral transmission.
    Daenke S; Booth S
    AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1731-6. PubMed ID: 11080818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton.
    Igakura T; Stinchcombe JC; Goon PK; Taylor GP; Weber JN; Griffiths GM; Tanaka Y; Osame M; Bangham CR
    Science; 2003 Mar; 299(5613):1713-6. PubMed ID: 12589003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of infiltrating T cells in the affected autoimmune lesions of HTLV-I transgenic rats].
    Sugaya T
    Hokkaido Igaku Zasshi; 2001 Jan; 76(1):35-47. PubMed ID: 11235211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unintegrated two-long terminal repeat circular human T lymphotropic virus DNA accumulation during chronic HTLV infection.
    Kitamura K; Besansky NJ; Rudolph D; Nutman TB; Folks TM; Lal RB
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1167-72. PubMed ID: 8312058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DC-SIGN mediates cell-free infection and transmission of human T-cell lymphotropic virus type 1 by dendritic cells.
    Jain P; Manuel SL; Khan ZK; Ahuja J; Quann K; Wigdahl B
    J Virol; 2009 Nov; 83(21):10908-21. PubMed ID: 19692463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HTLV-1 tropism and envelope receptor.
    Manel N; Battini JL; Taylor N; Sitbon M
    Oncogene; 2005 Sep; 24(39):6016-25. PubMed ID: 16155608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of functional conservation in the surface and transmembrane glycoprotein subunits of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2.
    Rosenberg AR; Delamarre L; Preira A; Dokhélar MC
    J Virol; 1998 Sep; 72(9):7609-14. PubMed ID: 9696862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Entry of human T-cell leukemia virus type 1 is augmented by heparin sulfate proteoglycans bearing short heparin-like structures.
    Tanaka A; Jinno-Oue A; Shimizu N; Hoque A; Mori T; Islam S; Nakatani Y; Shinagawa M; Hoshino H
    J Virol; 2012 Mar; 86(6):2959-69. PubMed ID: 22238310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The synthetic peptide P-197 inhibits human T-cell leukemia virus type 1 envelope-mediated syncytium formation by a mechanism that is independent of Hsc70.
    Brighty DW; Jassal SR
    J Virol; 2001 Nov; 75(21):10472-8. PubMed ID: 11581416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.